Evidence map›Paper›PMID 40872838›Full record

ArticleViruses2025

Herpes Simplex 2 Virus Depletes Cells of DEAD-Box Helicase 3 Protein by Packaging It into Virions.

Carmen Rita Piazza, Giulia Lottini, Paola Quaranta, Paola Perrera, Fabio Filippini, Michele Lai, Cristina Di Primio, Giulia Freer, Mauro Pistello

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carmen Rita PiazzaRetrovirus Center, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.ORCID 0000-0003-3966-0826
Giulia LottiniRetrovirus Center, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.ORCID 0000-0001-7902-9495
Paola QuarantaRetrovirus Center, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.ORCID 0000-0001-8828-0905
Paola PerreraRetrovirus Center, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.
Fabio FilippiniRetrovirus Center, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.ORCID 0009-0006-3309-763X
Michele LaiRetrovirus Center, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.ORCID 0000-0001-7597-123X
Cristina Di PrimioInstitute of Neuroscience, National Research Council of Italy, 56127 Pisa, Italy.ORCID 0000-0003-2140-3696
Giulia FreerRetrovirus Center, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.
Mauro PistelloRetrovirus Center, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.

Funding

Missione 4, Componente 2, Investimento 1.3 CUP: I53C24001430007 COC-1-2023-UNIPV ID S1.P0002 PNRR 2023.P20222HHXA CUP I53D23005860001POR-CREO (grant PANVIR) awarded by Regione Toscana, and First Health Pharmaceutical BV; INF-ACT [PE00000007]PRIN 2022: Missione 4 "Istruzione e Ricerca" 2022FRE3RH, CUP I53D23000480006PRIN PNRR 2022: Missione 4 "Istruzione e Ricerca" P20222YKP8. CUP I53D23005870001
6 · The paper itself

Abstract

Human DEAD-box helicase 3 (DDX3) is a multifunctional RNA helicase implicated in mRNA unwinding and the regulation of gene expression. While DDX3 has been extensively studied in the context of RNA virus replication, its role in DNA virus replication remains less understood. In this study, we explore the involvement of DDX3 in the life cycle of Herpes Simplex Virus type 2 (HSV-2), a double-stranded DNA virus. Silencing of DDX3 expression with siRNA significantly impaired HSV-2 replication, indicating that DDX3 supports viral propagation. Unexpectedly, HSV-2 infection led to a marked reduction in cellular DDX3 protein levels during in vitro replication in human cells, particularly at 24 h post-infection, corresponding to the peak of viral production. Notably, this decrease was not accompanied by a reduction in DDX3 mRNA levels, nor was it prevented by proteasome inhibition, suggesting an alternative mechanism of DDX3 depletion. Further analysis revealed substantial amounts of DDX3 protein within HSV-2 virions, supporting the hypothesis that DDX3 is packaged into viral particles during replication. We propose that HSV-2 exploits host DDX3 by incorporating it into progeny virions to facilitate early stages of infection in newly infected cells. However, no evidence linking DDX3 to the assembly process of HSV-2 particles was found. These findings expand the known functional repertoire of DDX3 and highlight its potential as a host factor co-opted by DNA viruses, suggesting a broader relevance in antiviral strategies.

Indexed as

DEAD-box RNA HelicasesHerpesvirus 2, HumanVirionVirus AssemblyCell LineChlorocebus aethiopsHost-Pathogen InteractionsHumansVirus ReplicationDDX3X protein, humanDEAD-box RNA HelicasesDEAD-box protein-3herpes simplex virus 2host factors for viral replication

Identifiers

PMID40872838
PMCPMC12390712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.